Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAMP3 | O60896 | 10/20 | 0.47 |
| ▸ | CALCR | P30988 | 10/20 | 0.47 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.46 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.46 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.46 |
| ▸ | CALCRL | Q16602 | 3/20 | 0.45 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.44 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.44 |
| ▸ | APLNR | P35414 | 1/20 | 0.44 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29378649 | 0.87 | RAMP3 (0.50) | RAMP3CALCR | |
| SCHEMBL30512538 | 0.86 | RAMP3 (0.50) | RAMP3CALCRAPLNR | |
| SCHEMBL31516397 | 0.86 | RAMP3 (0.50) | RAMP3CALCRCALCRLEPHA2 | |
| SCHEMBL30327352 | 0.86 | EPHA2 (0.47) | RAMP3CALCRCALCRLEPHA2 | |
| SCHEMBL30118981 | 0.86 | EPHA2 (0.47) | RAMP3CALCRCALCRLKEAP1EPHA2 | |
| SCHEMBL29466793 | 0.85 | EPHA2 (0.47) | CALCRLKEAP1EPHA2 | |
| SCHEMBL31232964 | 0.84 | EPHA2 (0.51) | RAMP3CALCRMAPK8MAPK9MAPK10 | |
| SCHEMBL29471333 | 0.84 | RAMP3 (0.48) | RAMP3CALCR | |
| SCHEMBL30676238 | 0.84 | EPHA2 (0.46) | RAMP3CALCREPHA2APLNR | |
| SCHEMBL31462062 | 0.83 | MAPK8 (0.48) | RAMP3CALCRMAPK8MAPK9MAPK10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4410827-A1 | GLP-1/GIP DUAL-TARGETED POLYPEPTIDE AND FUSION PROTEIN AND APPLICATIONS THEREOF | Sunshine Lake Pharma Co., Ltd. (CN) | 2024-08-07 | — | — | EP | disclosed |